MENU
+Compare
NRXS
Stock ticker: ASE
AS OF
Oct 17 closing price
Price
$3.03
Change
-$0.11 (-3.50%)
Capitalization
29.91M

NRXS Neuraxis Forecast, Technical & Fundamental Analysis

Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children... Show more

NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NRXS with price predictions
Oct 16, 2025

NRXS's RSI Oscillator peaks and leaves overbought zone

The 10-day RSI Indicator for NRXS moved out of overbought territory on October 16, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 5 instances where the indicator moved out of the overbought zone. In of the 5 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 16, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on NRXS as a result. In of 47 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for NRXS turned negative on October 16, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 20 similar instances when the indicator turned negative. In of the 20 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NRXS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

NRXS broke above its upper Bollinger Band on October 15, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 25 cases where NRXS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

NRXS moved above its 50-day moving average on September 17, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for NRXS crossed bullishly above the 50-day moving average on September 24, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NRXS advanced for three days, in of 88 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 39 cases where NRXS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NRXS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.037) is normal, around the industry mean (24.455). P/E Ratio (0.000) is within average values for comparable stocks, (54.854). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.181). Dividend Yield (0.000) settles around the average of (0.037) among similar stocks. P/S Ratio (6.988) is also within normal values, averaging (352.090).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NRXS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
NRXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

NRXS is expected to report earnings to rise 9.09% to -23 cents per share on November 24

Neuraxis NRXS Stock Earnings Reports
Q3'25
Est.
$-0.24
Q2'25
Beat
by $0.03
Q4'24
Missed
by $0.27
Q1'24
Missed
by $0.22
Q3'23
Missed
by $1.18
The last earnings report on August 12 showed earnings per share of -21 cents, beating the estimate of -25 cents. With 53.79K shares outstanding, the current market capitalization sits at 29.91M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
11550 N. Meridian Street
Phone
+1 812 689-0791
Employees
N/A
Web
http://www.neuraxis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARL15.440.32
+2.12%
American Realty Investors
MSI445.007.79
+1.78%
Motorola Solutions
FRO23.360.35
+1.52%
Frontline Plc
CRCT5.220.01
+0.19%
Cricut
MSW2.28-0.05
-2.15%
Ming Shing Group Holdings Ltd

NRXS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXS has been loosely correlated with CVM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if NRXS jumps, then CVM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXS
1D Price
Change %
NRXS100%
-5.71%
CVM - NRXS
58%
Loosely correlated
-5.04%
CTMX - NRXS
25%
Poorly correlated
-3.81%
NGNE - NRXS
24%
Poorly correlated
-1.11%
MNMD - NRXS
23%
Poorly correlated
-5.92%
MRVI - NRXS
23%
Poorly correlated
+3.56%
More